Docs comfy with ePromotion, and many prefer it, says study

Share this article:
Sixty-seven percent of physicians had a positive attitude toward electronic promotional activities, up from 62% a year ago, according to an SDI study.

Additionally, 73% of the physicians surveyed for SDI's ePromotion Annual Study 2008 said pharma's electronic promotional activities (or ePromotion) were equal or superior to traditional face-to-face encounters.

“Through ePromotion, physicians have more time to review product information and review disease state information at their own convenience – at night time or on the weekends,” said Heather Alba, senior manager, promotional audits at SDI.

Other findings from the report include:
  • Sixty-nine percent of the physicians surveyed participated in ePromotional activities in the evening, outside of office hours. 
  • In 2008, the average amount of time spent by a physician on a single ePromotion activity was 18 minutes. 
  • Physicians ranked Merck as the leader in terms of the best ePromotion activities, followed by Pfizer and AstraZeneca respectively. 
The study, which included feedback from approximately 1,000 physicians across 14 specialties, defined ePromotion in three categories: virtual details (promotions without live communication); video details (live online promotion or telephone-assisted internet browsing); and virtual events (seminars, CME and KOL events, web conferences and group discussions).
Share this article:
close

Next Article in News

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.